Kimberly Wolf joined BeiGene in 2024 as Senior Vice President, Global Commercial Strategy & Operations responsible for leading global commercial strategy and operations.

Previously, Kimberly was at Pfizer where she oversaw the Hematology and Biosimilars Global Commercial franchise, and more recently added the Lung and Precision Medicines business. Prior to Pfizer, Kimberly held leadership positions in both Commercial roles and in Clinical Research and Development at Bristol Myers Squibb/Celgene for more than 16 years, launching assets in cell therapy, Inflammation & Immunology, and Virology. Earlier in her career, she worked at GE, Pharmacia and Blue Cross Blue Shield of North Carolina.

Kimberly holds a Master of Public Health degree from the University of North Carolina at Chapel Hill and a B.A. in journalism from Washington and Lee University.